Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4750963
Max Phase: Preclinical
Molecular Formula: C57H60N6O9S2
Molecular Weight: 1037.27
Molecule Type: Unknown
Associated Items:
ID: ALA4750963
Max Phase: Preclinical
Molecular Formula: C57H60N6O9S2
Molecular Weight: 1037.27
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCOc2ccc(CNNC(=O)c3ccc(C(=O)c4c(-c5ccc(O)cc5)sc5cc(O)ccc45)cc3)cc2)C(C)(C)C)cc1
Standard InChI: InChI=1S/C57H60N6O9S2/c1-33(36-11-15-38(16-12-36)51-34(2)58-32-73-51)60-55(70)46-28-43(66)31-63(46)56(71)53(57(3,4)5)61-48(67)8-6-7-27-72-44-24-9-35(10-25-44)30-59-62-54(69)40-17-13-37(14-18-40)50(68)49-45-26-23-42(65)29-47(45)74-52(49)39-19-21-41(64)22-20-39/h9-26,29,32-33,43,46,53,59,64-66H,6-8,27-28,30-31H2,1-5H3,(H,60,70)(H,61,67)(H,62,69)/t33-,43+,46-,53+/m0/s1
Standard InChI Key: NLFBPUQABQUHHF-NZBPINMGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1037.27 | Molecular Weight (Monoisotopic): 1036.3863 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Lin X,Xiang H,Luo G. (2020) Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance., 206 [PMID:32829249] [10.1016/j.ejmech.2020.112689] |
Source(1):